Wei Chen1, Ming Zhu Bai1, Yixia Yang1, Di Sun1, Sufang Wu1, Jian Sun1, Yu Wu1, Youji Feng1, Youheng Wei2, Zijiang Chen3, Zhenbo Zhang4. 1. Reproductive Medicine Center, Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, 200080, China. 2. Institute of Bioscience and Biotechnology, Yangzhou University, Yangzhou, 225009, China. 3. Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, China. 4. Reproductive Medicine Center, Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, 200080, China. zhangzhenbozzb@shsmu.edu.cn.
Abstract
PURPOSE: Patients with Klinefelter syndrome (KS) who receive assisted reproductive technology (ART) treatment often experience poor pregnancy rates due to decreased fertilization, cleavage, and implantation rates and even an increased miscarriage rate. Mounting evidence from recent studies has shown that various technological advances and approaches could facilitate the success of ART treatment for KS patients. In this review, we summarize the methods for guiding KS patients during ART and for developing optimal strategies for preserving fertility, improving pregnancy rate and live birth rate, and avoiding the birth of KS infants. METHODS: We searched PubMed and Google Scholar publications related to KS patients on topics of controlled ovarian stimulation protocols, sperm extraction, fertility preservation, gamete artificial activation, round spermatid injection (ROSI), and non-invasive prenatal screening (PGD) methods. RESULTS: This review outlines the different ovulation-inducing treatments for female partners according to the individual sperm status in the KS patient. We further summarize the methods of retrieving sperm, storing, and freezing rare sperm. We reviewed different methods of gamete artificial activation and discussed the feasibility of ROSI for sterile KS patients who absolutely lack sperm. The activation of eggs in the process of intracytoplasmic sperm injection and non-invasive PGD are urgently needed to prevent the birth of KS infants. CONCLUSION: The integrated strategies will pave the way for the establishment of ART treatment approaches and improve the clinical outcome for KS patients.
PURPOSE:Patients with Klinefelter syndrome (KS) who receive assisted reproductive technology (ART) treatment often experience poor pregnancy rates due to decreased fertilization, cleavage, and implantation rates and even an increased miscarriage rate. Mounting evidence from recent studies has shown that various technological advances and approaches could facilitate the success of ART treatment for KS patients. In this review, we summarize the methods for guiding KS patients during ART and for developing optimal strategies for preserving fertility, improving pregnancy rate and live birth rate, and avoiding the birth of KS infants. METHODS: We searched PubMed and Google Scholar publications related to KS patients on topics of controlled ovarian stimulation protocols, sperm extraction, fertility preservation, gamete artificial activation, round spermatid injection (ROSI), and non-invasive prenatal screening (PGD) methods. RESULTS: This review outlines the different ovulation-inducing treatments for female partners according to the individual sperm status in the KS patient. We further summarize the methods of retrieving sperm, storing, and freezing rare sperm. We reviewed different methods of gamete artificial activation and discussed the feasibility of ROSI for sterile KS patients who absolutely lack sperm. The activation of eggs in the process of intracytoplasmic sperm injection and non-invasive PGD are urgently needed to prevent the birth of KS infants. CONCLUSION: The integrated strategies will pave the way for the establishment of ART treatment approaches and improve the clinical outcome for KS patients.
Authors: H Tournaye; C Staessen; I Liebaers; E Van Assche; P Devroey; M Bonduelle; A Van Steirteghem Journal: Hum Reprod Date: 1996-08 Impact factor: 6.918
Authors: Jonathan D Schiff; Gianpiero D Palermo; Lucinda L Veeck; Marc Goldstein; Zev Rosenwaks; Peter N Schlegel Journal: J Clin Endocrinol Metab Date: 2005-08-30 Impact factor: 5.958
Authors: M Kitamura; K Matsumiya; M Koga; K Nishimura; H Miura; T Tsuji; M Matsumoto; Y Okamoto; A Okuyama Journal: Int J Urol Date: 2000-03 Impact factor: 3.369
Authors: Ranjith Ramasamy; Joseph A Ricci; Gianpiero D Palermo; Lucinda Veeck Gosden; Zev Rosenwaks; Peter N Schlegel Journal: J Urol Date: 2009-07-18 Impact factor: 7.450